Literature DB >> 26861707

Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Peng Du1, John P Burke1, Wisam Khoury1, Ian C Lavery1, Ravi P Kiran1, Feza H Remzi1, David W Dietz2.   

Abstract

PURPOSE: The location of locally recurrent rectal cancer (LRRC) may influence survival. This study examines factors affecting the location of LRRC, the effect of LRRC location on survival, and predictive factors for survival in patients with LRRC.
METHODS: Patients undergoing initial proctectomy and subsequent management of LRRC at the Cleveland Clinic (1980-2011) were included. Data regarding index surgery, LRRC, and survival were obtained from a prospectively maintained database.
RESULTS: One hundred and fifty-seven patients were identified with a mean follow-up 59.8 ± 50.1 months and time to LRRC of 31.7 ± 30.1 months. Sixty patients underwent surgery with curative intent. Anastomotic leak and retrieving less than 12 lymph nodes at index proctectomy were associated with posterior (P = 0.019) and lateral (P = 0.036) recurrences, respectively. Having an axial relative to an anterior, posterior, or lateral recurrence was associated with improved overall survival (P = 0.001). On multivariable analysis, undergoing primarily palliative treatment (OR, 5.2; 95 % confidence interval (CI), 3.2-8.4; P < 0.001), age at LRRC >60 years (OR, 1.9; 95 % CI, 1.3-2.7, P < 0.001), advanced primary tumour stage (OR, 1.5; 95 % CI, 1.1-2.1; P = 0.021), and anastomotic leak at index surgery (OR, 1.8; 95 % CI, 1.2-2.7; P = 0.008) were associated with reduced LRRC 5-year survival.
CONCLUSIONS: The current study suggests that features of the primary tumour and technical factors at the time of index proctectomy influence both the location of LRRC and survival.

Entities:  

Keywords:  Local recurrence; Oncologic outcome; Rectal cancer; Survival

Mesh:

Year:  2016        PMID: 26861707     DOI: 10.1007/s00384-016-2526-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  36 in total

1.  Extended radical resection: the choice for locally recurrent rectal cancer.

Authors:  Alexander G Heriot; Christopher M Byrne; Peter Lee; Bruce Dobbs; Henry Tilney; Michael J Solomon; John Mackay; Frank Frizelle
Journal:  Dis Colon Rectum       Date:  2008-01-19       Impact factor: 4.585

2.  Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.

Authors:  Tony Milne; Michael J Solomon; Peter Lee; Jane M Young; Paul Stalley; James D Harrison
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

3.  Feasibility of reirradiation in the treatment of locally recurrent rectal cancer.

Authors:  S J Bosman; F A Holman; G A P Nieuwenhuijzen; H Martijn; G-J Creemers; H J T Rutten
Journal:  Br J Surg       Date:  2014-07-22       Impact factor: 6.939

4.  A population-based study on the management and outcome in patients with locally recurrent rectal cancer.

Authors:  G Palmer; A Martling; B Cedermark; T Holm
Journal:  Ann Surg Oncol       Date:  2006-12-02       Impact factor: 5.344

5.  The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.

Authors:  Wijnand J Alberda; Cornelis Verhoef; Marguerite E I Schipper; Joost J Nuyttens; Joost Rothbarth; Johannes H W de Wilt; Jabobus W A Burger
Journal:  Dis Colon Rectum       Date:  2015-07       Impact factor: 4.585

Review 6.  Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis.

Authors:  Alexander Mirnezami; Reza Mirnezami; Kandiah Chandrakumaran; Kishore Sasapu; Peter Sagar; Paul Finan
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

7.  Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement.

Authors:  Kirk K S Austin; Michael J Solomon
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

8.  Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.

Authors:  J M Young; T Badgery-Parker; L M Masya; M King; C Koh; A C Lynch; A G Heriot; M J Solomon
Journal:  Br J Surg       Date:  2014-01-13       Impact factor: 6.939

9.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Authors:  Jean-Pierre Gérard; David Azria; Sophie Gourgou-Bourgade; Isabelle Martel-Lafay; Christophe Hennequin; Pierre-Luc Etienne; Véronique Vendrely; Eric François; Guy de La Roche; Olivier Bouché; Xavier Mirabel; Bernard Denis; Laurent Mineur; Jean-François Berdah; Marc-André Mahé; Yves Bécouarn; Olivier Dupuis; Gérard Lledo; Jean-François Seitz; Laurent Bedenne; Béata Juzyna; Thierry Conroy
Journal:  J Clin Oncol       Date:  2012-10-29       Impact factor: 44.544

10.  Pelvic recurrence of rectal cancer. Options for curative resection.

Authors:  H J Wanebo; D L Gaker; R Whitehill; R F Morgan; W C Constable
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

View more
  3 in total

1.  Are risk factors for anastomotic leakage influencing long-term oncological outcomes after low anterior resection of locally advanced rectal cancer with neoadjuvant therapy? A single-centre cohort study.

Authors:  Peter Tschann; Markus P Weigl; Philipp Szeverinski; Daniel Lechner; Thomas Brock; Stephanie Rauch; Jana Rossner; Helmut Eiter; Paolo N C Girotti; Tarkan Jäger; Jaroslav Presl; Klaus Emmanuel; Alexander De Vries; Ingmar Königsrainer; Patrick Clemens
Journal:  Langenbecks Arch Surg       Date:  2022-07-18       Impact factor: 2.895

2.  Ultralow anterior resection with implantation of gentamicin-collagen sponge and no defunctioning stoma: anastomotic leakage and local cancer relapse.

Authors:  Tomasz Michalik; Rafał Matkowski; Przemyslaw Biecek; Jozef Forgacz; Bartlomiej Szynglarewicz
Journal:  Radiol Oncol       Date:  2019-03-03       Impact factor: 2.991

3.  Clinical Reality and Treatment for Local Recurrence of Rectal Cancer: A Single-Center Retrospective Study.

Authors:  Michał Jankowski; Manuela Las-Jankowska; Andrzej Rutkowski; Dariusz Bała; Dorian Wiśniewski; Karol Tkaczyński; Witold Kowalski; Iwona Głowacka-Mrotek; Wojciech Zegarski
Journal:  Medicina (Kaunas)       Date:  2021-03-19       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.